Success Metrics

Clinical Success Rate

80.0%

Based on 8 completed trials

Completion Rate

80%(8/10)

Active Trials

0(0%)

Results Posted

88%(7 trials)

Terminated

2(20%)

Phase Distribution

Ph phase_4

10%

Ph phase_2

30%

Ph phase_3

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 2Efficacy & side effects

3(30.0%)

Phase 3Large-scale testing

6(60.0%)

Phase 4Post-market surveillance

1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(2)

Detailed Status

Completed8

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (30.0%)

Phase 36 (60.0%)

Phase 41 (10.0%)

Trials by Status

completed880%

terminated220%

Recent Activity

0 active trials

Showing 5 of 10

terminatedphase_4

Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery

NCT05315479

completedphase_3

Clinical Trials (10)

Showing 10 of 10 trials

NCT05315479Phase 4

Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery

Terminated

NCT02720692Phase 3

Evaluation of N1539 Following Major Surgery

Completed

NCT03323385Phase 3

Evaluation of Preoperative N1539 in Colorectal Surgery

Completed

NCT03434275Phase 3

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

Completed

NCT02678286Phase 3

Evaluation of N1539 Following Abdominoplasty Surgery

Completed

NCT02675907Phase 3

Evaluation of N1539 Following Bunionectomy Surgery

Completed

NCT02540265Phase 2

Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

Completed

NCT01436032Phase 3

Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

Terminated

NCT00945763Phase 2

Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

Completed

NCT01084161Phase 2

Study to Evaluate the Efficacy, Safety and Tolerability of N1539

Completed

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10